--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About PRAX20260821C310
Biological Technology
Praxis Precision Medicines, Inc., was incorporated under the laws of the State of Delaware on September 22, 2015. The company is a clinical-stage biopharmaceutical company that translates genetic insights into the development of treatments for the central nervous system (CNS), a disease characterized by neuronal imbalance.
